Overview of Dr. Rangnekar Dr. Amol Rangnekar is a gastroenterologist in Washington, DC and is affiliated with MedStar Georgetown University Hospital. He received his medical degree from McGaw Medical Center of Northwestern University and has been in practice 12 years. He is one of 76 doctors at MedStar Georgetown University Hospital who specialize in Gastroenterology. He has more than 20 publications and over 350 citings.
Education & Training New York Presbyterian Hospital (Columbia Campus) Fellowship, Transplant Hepatology, 2012 - 2013
University of Michigan Health System Fellowship, Gastroenterology, 2009 - 2012
University of Michigan Health System Residency, Internal Medicine, 2006 - 2008
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses) Internship, Internal Medicine, 2005 - 2006
Northwestern University The Feinberg School of Medicine Class of 2005
Certifications & Licensure MD State Medical License 2015 - 2023
VA State Medical License 2014 - 2024
DC State Medical License 2013 - 2024
NY State Medical License 2012 - 2014
MI State Medical License 2006 - 2015
American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Gastroenterology American Board of Internal Medicine Transplant Hepatology Publications & Presentations PubMed
The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes.
Nikki Duong, Brett Sadowski, Amol S. Rangnekar> ;Clinics in Liver Disease. 2021 Apr 1 PRO: Cardiac Catheterization Is the Optimal Strategy for Cardiovascular Risk Stratification in This Patient.
Brett Sadowski, Tilak Baba, Amol S. Rangnekar> ;Clinics in Liver Disease. 2021 Jan 1 Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma
Nicole E. Rich, Ju Dong Yang, Ponni V. Perumalswami, Naim Alkhouri, Whitney E. Jackson, Neehar D. Parikh, Neil Mehta, Reena Salgia, Andres Duarte-Rojo, Laura Kulik, Mi...> ;Clinical Gastroenterology and Hepatology. 2020 Apr 1 Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
Amit G. Singal, Nicole E. Rich, Neil Mehta, Andrea D. Branch, Anjana Pillai, Maarouf Hoteit, Michael L. Volk, Mobolaji Odewole, Steven Scaglione, Jennifer Guy, Adnan S...> ;Gastroenterology. 2019 Nov 1 Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.
Alexander Dao, Mohamed Modar Abidian, Aimee LeStrange, Mark C. Mattar, Amol S. Rangnekar, Aline Charabaty> ;Inflammatory Bowel Diseases. 2019 Jun 18 Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Amit G. Singal, Nicole E. Rich, Neil Mehta, Andrea D. Branch, Anjana Pillai, Maarouf Hoteit, Michael L. Volk, Mobolaji Odewole, Steven J. Scaglione, Jennifer Guy, Adna...> ;Gastroenterology. 2019 May 1 Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?
Alexander E Dao, Amol S. Rangnekar> ;Clinics in Liver Disease. 2018 Dec 1 Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
Cristina Di Poto, Shisi He, Rency S. Varghese, Yi Zhao, Alessia Ferrarini, Shan Su, Abdullah Karabala, Mesfin Redi, Hassen Mamo, Amol S. Rangnekar, Thomas M. Fishbein,...> ;PLOS ONE. 2018 Mar 14 Low frequency of polyps in colonic regions with diverticulosis.
Irving Levine, Amol S. Rangnekar, Aaron Tokayer> ;International Journal of Colorectal Disease. 2017 Sep 7 The Effect of Hospital Characteristics on Racial/Ethnic Variation in Cirrhosis Mortality
Apurba Chakrabarti, Nicholas H. Osborne, Amol S. Rangnekar, Amit K. Mathur> ;Journal of racial and ethnic health disparities. 2017 Apr 11 Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study.
Robert J. Fontana, Caitlyn Ellerbe, Valerie E. Durkalski, Amol S. Rangnekar, Rajender Reddy, Todd Stravitz, Brendan M. McGuire, Timothy Davern, Adrian Reuben, Iris Lio...> ;Liver International. 2015 Feb 1 Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients.
Amol S. Rangnekar, Caitlyn Ellerbe, Valerie Durkalski, Brendan M. McGuire, William M. Lee, Robert J. Fontana> ;Liver Transplantation. 2013 Sep 1 IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysis.
Amol S. Rangnekar, Robert J. Fontana> ;Journal of Viral Hepatitis. 2013 Jun 1 Meta‐analysis: IL‐28B genotype and sustained viral clearance in HCV genotype 1 patients
A. S. Rangnekar, Robert J. Fontana> ;Alimentary Pharmacology & Therapeutics. 2012 Jul 1 Managing drug‐drug interactions with boceprevir and telaprevir
Amol S. Rangnekar, Robert J. Fontana> ;Clinics in Liver Disease. 2012 Apr 1 Erratum to: Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with Gastrointestinal Bleeding.
Elmunzer, B.J., Padhya, K.T., Lewis, J.J., Rangnekar, A.S., Saini, S.D., Eswaran, S.L., Scheiman, J.M., Pagani, F.D., Haft, J.W., Waljee, A.K.> ;Dig Dis Sci. 2011-09-10 Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleeding.
B. Joseph Elmunzer, Kunjali Padhya, Jason J. Lewis, Amol S. Rangnekar, Sameer D. Saini, Shanti Eswaran, James M. Scheiman, Francis D. Pagani, Jonathan W. Haft, Akbar K...> ;Digestive Diseases and Sciences. 2011 Jul 27 Continuing medical education questions: july 2011.
Devault, K.R., Rangnekar, A.S., Lewis, J.> ;Am J Gastroenterol. 2011-07-01 An update on drug induced liver injury.
Rangnekar, A. S.,Fontana, R. J.> ;Minerva Gastroenterol Dietol. 2011 May 19 Continuing medical education questions: may 2011.
> ;Am J Gastroenterol. 2011-05-01 The FODMAP diet for irritable bowel syndrome: food fad or roadmap to a new treatment paradigm?
Amol S. Rangnekar, William D. Chey> ;Gastroenterology. 2009 Jul 1 Methylnaltrexone: a new treatment for an old problem.
Amol S. Rangnekar, William D. Chey> ;Gastroenterology. 2008 Nov 1 Review: tissue transglutaminase test is almost as accurate as endomysial antibody test for diagnosis of coeliac disease.
Amol S. Rangnekar, William D Chey> ;Archives of Disease in Childhood-education and Practice Edition. 2007 Feb 1 Review: tissue transglutaminase test is almost as accurate as endomysial antibody test for diagnosis of coeliac disease
Amol S. Rangnekar, William D Chey> ;Evidence-based Medicine. 2007 Feb 1 Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
Amol S. Rangnekar, Frank Lammert, Alexander Igolnikov, Richard M. Green> ;Liver International. 2006 Oct 1 Join now to see all 
New York Presbyterian Hospital (Columbia Campus)Fellowship, Transplant Hepatology, 2012 - 2013
University of Michigan Health SystemFellowship, Gastroenterology, 2009 - 2012
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2005 - 2006
Northwestern University The Feinberg School of MedicineClass of 2005
MD State Medical License 2015 - 2023
VA State Medical License 2014 - 2024
DC State Medical License 2013 - 2024
NY State Medical License 2012 - 2014
MI State Medical License 2006 - 2015
MedStar Georgetown University HospitalWashington, District of Columbia
